We are proud to announce a landmark achievement. The Department of Medical Microbiology and Immunology, Faculty of Health Sciences, at the University of Nairobi, in partnership with the Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine at the University of Manitoba, has been awarded a significant grant of approximately 70 million Kenyan Shillings (KSH) from the Canadian International Development Scholarships 2030 (BCDI 2030). This substantial funding marks a pivotal milestone in the fields of medical microbiology, immunology, and infectious diseases.
Led by Dr. Marianne Mureithi the Chair, Department of Medical Microbiology and Immunology (UoN) and Prof. Keith Fowke the Chair, Department of Medical Microbiology & Infectious Diseases (UM), this funding marks a major step in tackling critical issues such as emerging infectious diseases, antimicrobial resistance, and genomic surveillance. The grant will empower fully-funded PhD students and student interns from the University of Nairobi, offering them an extraordinary opportunity for advanced studies and capacity building at the University of Manitoba.
Dr. Mureithi shared her excitement about this achievement: "This grant is a clear affirmation of our dedication to advancing global health research. We are immensely excited to see our innovative approach to medical research being acknowledged and supported at this level."
Echoing her sentiment, Prof. Fowke commented: "This collaboration stands as a testament to the power of international partnerships in pushing the frontiers of science and education. We are honored to be involved in this transformative project."
This generous grant will fund the studies and capacity-building endeavors of 3 PhD students and 5 interns from the University of Nairobi, who will have the opportunity to enhance their skills and knowledge at the University of Manitoba. This aspect of the program showcases the strength and ingenuity of the longstanding collaboration between these two prestigious institutions.
We express our deepest gratitude for this opportunity, which is set to play a crucial role in addressing significant global health challenges, such as infectious diseases and antimicrobial resistance, through state-of-the-art research and comprehensive training.